Tetrabenazine

Overview

Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor used to treat hyperkinetic movement disorders such as Huntington's disease. It reduces the excess dopamine activity in the brain that contributes to these disorders.

API suppliers (8)

Suppliers of Tetrabenazine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• MATRIX PHARMACORP PRIVATE LTD2 active DMF
• CORDEN PHARMA CHENOVEFrance1 active DMF
• CORDEN PHARMA CHENOVEFrance1 active DMF
• CORDEN PHARMA CHENOVEFrance1 active DMF
• CORDEN PHARMA CHENOVEFrance1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• ROLABO OUTSOURCING SL1 active DMF
• CORDEN PHARMA CHENOVEFrance1 active DMF

Therapeutic areas